Evaluation of the efficiency of hyaluronic acid, PRP and I-PRF intra-articular injections in the treatment of internal derangement of the temporomandibular joint: A prospective study

J Craniomaxillofac Surg. 2023 Jan;51(1):1-6. doi: 10.1016/j.jcms.2023.01.017. Epub 2023 Jan 28.

Abstract

This study aimed to evaluate the clinical effects of hyaluronic acid (HA), platelet-rich plasma (PRP), and platelet-rich fibrin (I-PRF) injections in the internal derangement of the temporomandibular joint. Adult patients who had failed to respond to nonsurgical treatment were were included in the study. The patients were divided into three treatment groups according to the given substance: 1) HA administration three times in a row on a weekly basis, 2) a single dose of PRP, or 3) a single dose of I-PRF. Clinical assessment was performed preoperatively and 6 and 12 months after the treatment, including maximal mouth opening (MMO) and pain level (Visual Analog Scale). Low and high molecular weight (HAL, HAH) hyaluronic acid forms were also compared. 68 adult patients, with a total of 109 joints were included in the study. The mean age was 53 ± 16 years. The statistical analysis showed a significant improvement in MMO in the HA group (p < 0.01). The pain level significantly decreased in all treatment groups (pHA,PRP,I-PRF<0.01). Comparing HAL and HAH forms, no significant difference was found in the evaluation of MMO and VAS values. Within the limitations of the study it seems that due to the similar effects of HA and the autologous blood substances, the platelet concentrates should be preferred in the intra-articular treatment in order to reduce the risk of possible adverse effects.

Keywords: Hyaluronic acid; Intra-articular injection; Platelet-rich fibrin; Platelet-rich plasma; Temporomandibular disorder.

MeSH terms

  • Adult
  • Aged
  • Humans
  • Hyaluronic Acid*
  • Injections, Intra-Articular
  • Middle Aged
  • Pain / drug therapy
  • Platelet-Rich Plasma*
  • Prospective Studies
  • Temporomandibular Joint
  • Treatment Outcome

Substances

  • Hyaluronic Acid